Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00YBW
|
|||
| Former ID |
DIB001905
|
|||
| Drug Name |
OXY-111A
|
|||
| Synonyms |
OXYRENS; Myo-inositol trispyrophosphate; Oxyren (oxygen release enhancer) haemoglobin-oxygen affinity allosteric modulators (Cardiovascular disease/cancer), NormOxys
Click to Show/Hide
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Phase 1/2 | [1] | |
| Company |
NormOxys Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02528526) Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm. | |||
| REF 2 | Modulating the oxygen affinity of human fetal haemoglobin with synthetic allosteric modulators. Br J Haematol. 1998 Sep;102(5):1165-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.